PATENT CLAIM ANALYSIS

Application Number: 16226070
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["514", "210200"]

Abstract:
Provided are a pyrimidine compound represented by Formula 1, a method of preparing the same, and a pharmaceutical use of the pyrimidine compound for the prevention or treatment of cancer.

Claim (Index 10):
The compound of  claim 1 , wherein\n R 7  is hydrogen or a C 3-7  cycloalkyl group, Y is a direct bond or \u2014CH 2 \u2014, Z is Formula 4 or Formula 5, R 8  is hydrogen, a linear or branched C 1-4  alkyl group, a linear or branched hydroxy C 1-4  alkyl group, a heterocycloalkyl group, or a hydroxy substituted heterocycloalkyl group, and R 15 (s) are each independently a linear or branched C 1-4  alkyl group, a linear or branched hydroxy C 1-4  alkyl group, or a halogen.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 98.0
- Lexical Diversity: 1.375
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16127487', '15319151', '12843494', '15565897', '12002340']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8160253090476454
- 35 USC 102 Novelty (BERT): 0.6005328097118445
- Combined Prediction Score: 0.7944760591140653
- Mean Citation Score: 352.326112
- Max Citation Score: 527.59644
- Similarity Product: 472.3352845779133

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test